Ron Moldaver | Investor Relations |
James Mullen | Chief Executive Officer |
Mark Shearman | EVP and Chief Scientific Officer |
Lisa Michaels | EVP and Chief Medical Officer |
Michelle Robertson | Chief Financial Officer |
Gena Wang | Barclays Capital |
Costa Sean | Morgan Stanley & Co. |
Phil Nadeau | Cowen & Company |
Yanan Zhu | Wells Fargo Securities |
Cory Kasimov | J.P. Morgan Securities |
Joon Lee | Truist Securities |
Jonathan Golub | Credit Suisse |
Steven Seedhouse | Raymond James |
Jay Olson | Oppenheimer & Co. |
Madhu Kumar | Goldman Sachs & Co. |
Liisa Bayko | Evercore ISI |
Luca Issi | RBC Capital Markets |
Good morning and welcome to Editas Medicine Second Quarter 2021 Conference Call. All participants are now in a listen-only mode. [Operator Instructions] I would now like to turn the call over to Ron Moldaver, Investor Relations at Editas Medicine.
Thank you, Darryl. Good morning, everyone, and welcome to our second quarter 2021 conference call.